NorthEdge invests in life sciences marketing agency ramarketing
The investment comes from NorthEdge’s £125M SME fund.
Private equity firm NorthEdge has completed its investment in life sciences marketing agency ramarketing, which will support an expansion of the firm's services and increased international presence.
Ramarketing is a full-service marketing firm that supports clients in the pharmaceutical and biotech industries. According to the company, it is regarded as one of the fastest-growing life sciences agencies in the world.
NorthEdge’s investment will help ramarketing to increase the range of services it offers and further expand its US footprint, building on its presence in Boston, MA.
Raman Sehgal, founder and Global President of ramarketing, said this marks a new chapter in the company’s evolution.
‘We are evolving into the type of next-generation growth partner that our clients will need in the future. Data-driven, embedded in industry and truly global,’ he said.
‘That type of ambition requires the right partner, hence why I am really looking forward to growing the business in partnership with the NorthEdge team over the coming years.’
Emma Banks, Managing Director of ramarketing added: “It’s a hugely exciting time for the global life sciences industry, and we are perfectly positioned to grow our market offering in line with the demand. Our HQ in Newcastle is part of a fast-growing life sciences hub serving a global market, with 86% of North East pharmaceutical production exported internationally, while our US base in Boston sits in the epicenter of the global life sciences corridor, so we have all the horsepower we need to support our clients across the world.’
She continued: ‘The support from NorthEdge will enable us to supercharge our creative, content and digital service offerings, while also investing in our diverse and talented team – providing genuine technical marketing expertise and deep sector knowledge, delivered the ramarketing way, across the life sciences industry.’
The investment was funded from NorthEdge’s £125 million SME Fund I and marks the private equity firm’s third deal in the life sciences sector over the last 18 months.
Liam May, Director at NorthEdge said: ‘The North East is a great place for investment, evidenced by an increasing volume of start-ups and a number of initiatives designed to turbo charge growth in the area – with health and life sciences being identified as a key growth sector for the region. ramarketing is a great example of a quality business based in the region that is shaping a global market, and we are excited to be a part of its journey.’
Ramarketing founder Raman Sehgal will lead a pharma marketing and strategy workshop at this year’s CPHI North America event – find out more here.
Related News
-
News How to disrupt an industry as big as pharma for the better?
In this interview, hear from Matthew Wise, Head of Data at CCD Partners, on the companies they've been looking into that are offering new and interesting perspectives that have the potential to shake up the pharmaceutical industry, and how they'... -
News CPHI Pharma Awards 2024: Meet the winners from the CPHI Celebration
This year we had a lot to celebrate, the 35th Anniversary of CPHI, and our esteemed award winners, of which we included two additional categories this year, the Future Leader award, and Woman of the Year award. -
News CPHI Milan 2024 - From the Floor
Milan and CPHI welcome you to 2024 CPHI Milan! As we celebrate the 35th edition of our flagship CPHI show, editors Vivian Xie and Lucy Chard bring you the latest from the show floor, conference sessions, and innovative solutions from all exhibitors, at... -
News AstraZeneca invests in AI collaboration for cancer drug trials
The British-Swedish pharmaceutical giant is partnering with biotechnology firm Immunai Inc to increase the efficiency of some cancer drug trials. -
News CPHI Podcast Series: The power of proteins in antibody drug development
In the latest episode of the CPHI Podcast Series, Lucy Chard is joined by Thomas Cornell from Abzena to discuss protein engineering for drug design and development. -
News A Day in the Life of a Global CDMO Chapter Lead – Manufacturing
The 'Day in the Life of' series has covered many aspects of the pharmaceutical pipeline, including R&D and procurement, now we're taking a look at manufacturing from a global CDMO perspective. -
News Eisai Alzheimer’s drug authorised in UK but still faces obstacles
In partnership with BioArctic AB, pharmaceutical company Eisai has been granted Marketing Authorisation by the Medicines and Healthcare products Regulatory Agency (MHRA) for its Alzheimer’s disease drug product Leqembi. -
News Sanofi invests billions into Frankfurt insulin production site
French pharmaceutical company Sanofi have announced an investment of EUR1.3 billion at their existing BioCampus site in Frankfurt am Main for the expansion of insulin production.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance